Molecular epidemiology of papillary thyroid cancer: In search of common genetic associations

Thyroid

Volumn 19, Issue 10, 2009, Pages 1031-1034

  Sturgis, Erich M ^a   Li, Guojun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; NIBRIN; NUCLEIC ACID BINDING PROTEIN; PROTEIN PATCHED; PROTEIN RET; RAD51 PROTEIN; UNCLASSIFIED DRUG; XRCC1 PROTEIN; XRCC2 PROTEIN; XRCC3 PROTEIN;

ALCOHOL CONSUMPTION; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; DIET; DNA REPAIR; EDITORIAL; HUMAN; IONIZING RADIATION; MUTATIONAL ANALYSIS; PAPILLARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; THYROID CANCER;

CARCINOMA, PAPILLARY; DNA REPAIR; HUMANS; POLYMORPHISM, GENETIC; RISK ASSESSMENT; THYROID NEOPLASMS;

EID: 70350676482     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.1597     Document Type: Editorial

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ 2009 Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
2. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167.
3. Chen AY, Jemal A, Ward EM 2009 Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115:3801-3807.
4. Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB 2008 Recent advances in thyroid cancer. Curr Prob Surg 45:156-250.
5. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D 1998A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63: 1743-1748.
6. McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L, Burgess J, Duffield A, Papotti M, Stark M, Sobol H, Maes B, Murat A, Kääriäinen H, Bertholon-Grégoire M, Zini M, Rossing MA, Toubert ME, Bonichon F, Cavarec M, Bernard AM, Boneu A, Leprat F, Haas O, Lasset C, Schlumberger M, Canzian F, Goldgar DE, Romeo G 2001 Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69:440-446.
7. Harb WJ, Sturgis EM 2009 Differentiated thyroid cancer associated with intestinal polyposis syndromes: a review. Head Neck (epub, published online ahead of print, DOI 10.1002=hed.21156).
8. Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH, Klempnauer J 2000 Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg 24:1409-1417.
9. Shattuck TM, Westra WH, Ladenson PW, Arnold A 2005 Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. New Engl J Med 352: 2406-2412.
10. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH 1994 Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608.
11. Czene K, Lichtenstein P, Hemminki K 2002 Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database. Int J Cancer 99: 260-266.
12. Hou P, Xing M 2006 Absence of germline mutations in genes within the MAP kinase pathway in familial non-medullary thyroid cancer. Cell Cycle 5:2036-2039.
13. Xing M 2005 The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol 63:263-266.
14. Bastos HN, Antão MR, Silva SN, Azevedo AP, Manita I, Teixeira V, Pina JE, Gil OM, Ferreira TC, Limbert E, Rueff J, Gaspar JF 2009 Association of polymorphisms in genes of the homologous recombination repair pathway and thyroid cancer risk. Thyroid 19:1067-1075.
15. Sturgis EM, Zhao C, Zheng R, Wei Q 2005 Radiation response genotype and risk of differentiated thyroid cancer: A case-control analysis. Laryngoscope 115:938-945.
16. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F 2001 RET=PTC rearrangements in thyroid nodules: Studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86:3211-3216.
17. Hamatani K, Eguchi H, Ito R, Mukai M, Takahashi K, Taga M, Imai K, Cologne J, Soda M, Arihiro K, Fujihara M, Abe K, Hayashi T, Nakashima M, Sekine I, Yasui W, Hayashi Y, Nakachi K 2008 RET=PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Cancer Res 68: 7176-7182.
18. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57:1690-1694.
19. Volpato CB, Martinez-Alfaro M, Corvi R, Gabus C, Sauvaigo S, Ferrari P, Bonora E, De Grandi A, Romeo G 2008 Enhanced sensitivity of the RET proto-oncogene to ionizing radiation in vitro. Cancer Res 68:8986-8992.
20. Fenton CL, Lukes Y, Nicholson D, Dinauer CA, Francis GL, Tuttle RM 2000 The ret=PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab 85:1170-1175.
21. Kinashi Y, Sakurai Y, Masunaga S, Suzuki M, Nagata K, Ono K 2007 Evaluation of micronucleus induction in lymphocytes of patients following boron-neutron-capture-therapy: A comparison with thyroid cancer patients treated with radioiodine. J Radiat Res 48:197-204.
22. Xiong P, Zheng R, Wang LE, Bondy ML, Shen H, Borer M, Wei Q, Sturgis EM 2005A pilot case-control study of gamma radiation sensitivity and risk of papillary thyroid cancer. Thyroid 15:94-99.
23. Sigurdson AJ, Hauptmann M, Alexander BH, Doody MM, Thomas CB, Struewing JP, Jones IM 2005 DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutation Res 586:173-188.
24. Adjadj E, Schlumberger M, de Vathaire F 2009 Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol 10:181-190.
25. Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, Mitsutake N, Kominami R, Yamashita S 2009 Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocrine Rel Cancer 16:491-503.
26. Chiang FY, Wu CW, Hsiao PJ, Kuo WR, Lee KW, Lin JC, Liao YC, Juo SHH 2008 Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res 14:5919-5924.
27. Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymanska A, Szymanska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubinski J 2004 CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75:1131-1135. (Pubitemid 39532081)
28. Dombernowsky SL, Weischer M, Allin KH, Bojesen SE, Tybjoerg-Hansen A, Nordestgaard BG 2008 Risk of cancer by ATM missense mutations in the general population. J Clin Oncol 26:3057-3062.
29. Ho T, Li G, Zhao C, Lu J, Wei Q, Sturgis EM 2009 Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid 19: 129-135.
30. Silva SN, Gil OM, Oliveira VC, Cabral MN, Azevedo AP, Faber A, Manita I, Ferreira TC, Limbert E, Pina JE, Rueff J, Gaspar J 2005 Association of polymorphisms in ERCC2 gene with non-familial thyroid cancer risk. Cancer Epidemiol Biomarkers Prev 14:2407-2412.
31. Siraj AK, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O, Uddin S, Al-Kuraya K 2008 RAD 52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J Endocrinol Invest 31:893-899.
32. Gaspar J, Rodrigues S, Gil OM, Manita I, Ferreira TC, Limbert E, Gonçalves L, Pina JE, Rueff J 2004 Combined effects of glutathione S-transferase polymorphisms and thyroid cancer risk. Cancer Genet Cytogenet 151:60-67.
33. Granja F, Morari J, Morari EC, Correa LAC, Assumpcao LVM, Ward LS 2004 Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Let 210:151-157.
34. Ho T, Li G, Zhao C, Wei Q, Sturgis EM 2005 RET protooncogene polymorphisms=haplotypes and risk of differentiated thyroid cancer: a case-control analysis. Laryngoscope 115:1035-1041.
35. Ho T, Zhao C, Zheng R, Liu Z, Wei Q, Sturgis EM 2006 Glutathione-S- transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis. Arch Otolaryngol Head Neck Surg 132:756-761. (Pubitemid 44086439)
36. Ho T, Li G, Zhao C, Zheng R, Wei Q, Sturgis EM 2008 Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis. Head Neck 30:297-305.
37. Morari EC, Leite JL, Granja F, da Assumpcao LV, Ward LS 2002 The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol Biomarkers Prev 11:1485-1488.
38. Rogounovitch TI, Saenko VA, Ashizawa K, Sedliarou IA, Namba H, Abrosimov AY, Lushnikov EF, Roumiantsev PO, Konova MV, Petoukhova NS, Tchebotareva IV, Ivanov VK, Chekin SY, Bogdanova TI, Tronko MD, Tsyb AF, Thomas GA, Yamashita S 2006 TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Oncol Rep 15:949-956.
39. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464.